Benzinga's Top Downgrades

By: Benzinga
Analysts at Bank of America downgraded ViroPharma (NASDAQ: VPHM ) from “neutral” to “underperform.” The target price for ViroPharma is set to $34. ViroPharma's shares closed at $40.78 yesterday. Morgan Stanley downgraded Intuit (NASDAQ: INTU ) from “equal-weight” to “underweight.” The target price for Intuit is set to
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.